Category: IN-DEPTH STORIES
Biosimilars: The Evolution of a New Industry (Review)
KEY POINTS The global oncology mAb market is expected to reach around $45 billion by the end of this decade. ...
Liquid Biopsy: The Golden Cancer Diagnostic Test (an Industrial Review)
KEY POINTS The liquid biopsy market is forecasted to grow at a CAGR of 20.6 percent to reach over $3 ...
World’s 10 Top-Selling Orphan Drugs 2018
KEY POINTS Here are the 10 top-selling orphan drugs in terms of their worldwide sales in the previous financial year. ...
Top Companies Leading the Rare Disease Drug Discovery (2018)
KEY POINTS Here are the six companies playing on the front foot in the segment of rare diseases drug discovery. ...
10 Potential Drugs in Development for Alzheimer’s Disease (2018)
KEY POINTS Here are the potential Alzheimer’s disease drug candidates in the late stage of clinical development in 2018. Companies ...
Migraine Treatment: The Current Status and New Effective Medicines in Trials (2018)
KEY POINTS Breakthrough discovery of the role of Calcitonin Gene-Related Peptide (CGRP) in the development of a migraine has created ...
The Front Runners Drug Companies in Tackling ‘Superbugs’
KEY POINTS First independent assessment of the global work has been performed to tackle Antimicrobial Resistance (AMR) worldwide. GlaxoSmithKline and ...
NASH Disease: The Story of Industrial Ignorance and Attention
Highlights A comprehensive review of the past and current status of the Non-Alcoholic Steatohepatitis (NASH) drug discovery pipeline. Once thought to be ...